MAMMOTH BIOSCIENCES
Mammoth Biosciences is harnessing the diversity of nature to power the next-generation of CRISPR products. Through the discovery and development of novel CRISPR systems, the company is enabling the full potential of its platform to read and write the code of life. Mammoth Biosciences aims to democratize disease detection with an easy and affordable point-of-care test that allows real-time and simultaneous detection of multiple conditions. By leveraging its internal research and development and ... exclusive licensing to Cas12, Cas13, and Cas14, Mammoth Biosciences can provide enhanced diagnostics and genome editing for life science research, healthcare, agriculture, biodefense and more. Based in South San Francisco, Mammoth Biosciences is co-founded by CRISPR pioneer Jennifer Doudna and principal founders Trevor Martin, Janice Chen, and Lucas Harrington. The firm is backed by top institutional investors including Mayfield, NFX, and 8VC, Decheng Capital and leading individual investors including Brook Byers, Tim Cook, and Jeff Huber. Mammoth has also been working on developing a rapid COVID-19 test.
MAMMOTH BIOSCIENCES
Industry:
Biotechnology Genetics Health Diagnostics Life Science
Founded:
2017-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.mammoth.bio
Total Employee:
101+
Status:
Active
Contact:
+1-650-294-8583
Total Funding:
264.55 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Wordpress Plugins
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Board_member
Board_member
2020-01-30
Advisor
2020-01-30
Board_member
Board_observer
2019-01-01
Board_member
2020-01-30
Current Employees Featured
Trevor Martin Co-Founder and CEO @ Mammoth Biosciences
Co-Founder and CEO
2017-05-01
Jennifer Doudna Co-Founder @ Mammoth Biosciences
Co-Founder
Lucas Harrington Co-Founder, Chief Scientific Officer @ Mammoth Biosciences
Co-Founder, Chief Scientific Officer
Janice Chen Co-Founder, Chief Technology Officer @ Mammoth Biosciences
Co-Founder, Chief Technology Officer
Ted Tisch Chief Operating Officer @ Mammoth Biosciences
Chief Operating Officer
2019-07-01
Rachel Herder Vice President of Intellectual Property (IP) @ Mammoth Biosciences
Vice President of Intellectual Property (IP)
Gary Loeb General Counsel @ Mammoth Biosciences
General Counsel
Jesus Ching VP of R&D @ Mammoth Biosciences
VP of R&D
2020-01-01
Kevin Grossenbacher Director, Project Management @ Mammoth Biosciences
Director, Project Management
Peter Nell CBO and Head of Therapeutics @ Mammoth Biosciences
CBO and Head of Therapeutics
Founder
Investors List
Bradley Horowitz
Bradley Horowitz investment in Series D - Mammoth Biosciences
Plum Alley Investments
Plum Alley Investments investment in Series D - Mammoth Biosciences
Decheng Capital
Decheng Capital investment in Series D - Mammoth Biosciences
Senator Investment Group
Senator Investment Group investment in Series D - Mammoth Biosciences
Redmile Group
Redmile Group investment in Series D - Mammoth Biosciences
Sixth Street
Sixth Street investment in Series D - Mammoth Biosciences
Foresite Capital
Foresite Capital investment in Series D - Mammoth Biosciences
NFX
NFX investment in Series D - Mammoth Biosciences
Tachyon Ventures
Tachyon Ventures investment in Series D - Mammoth Biosciences
Mayfield Fund
Mayfield Fund investment in Series D - Mammoth Biosciences
Official Site Inspections
http://www.mammoth.bio Semrush global rank: 2.3 M Semrush visits lastest month: 8.15 K
- Host name: 151.101.194.159
- IP address: 151.101.194.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Mammoth Biosciences"
Mammoth Biosciences
Hi, we’re Mammoth. We are scientists, engineers, entrepreneurs, and dreamers who are building the CRISPR platform to deliver on the full promise of genetic medicine. With a distinguished …See details»
Mammoth Biosciences - Wikipedia
Mammoth Biosciences is a biotechnology company based in Brisbane, California [1] developing diagnostic tests using CRISPR-Cas12a and CRISPR-based therapies using its proprietary …See details»
Mammoth Biosciences - Crunchbase Company Profile …
Mammoth Biosciences is harnessing the diversity of nature to power the next-generation of CRISPR products. Through the discovery and development of …See details»
Therapeutics - Mammoth Biosciences
Example domain organization of NanoCas and CasPhi compared to commonly used variants of Cas9 and Cas12 with the nuclease domains (RuvC and HNH) indicated. Protein lengths are drawn to scale. ... Mammoth is committed to …See details»
Mammoth Biosciences Inc. - Life-Sciences-Europe.com
Mammoth aims to democratize disease detection with an easy and affordable point-of-care test that allows real-time and simultaneous detection of multiple conditions. By leveraging its …See details»
Mammoth Biosciences CEO and Key Executive Team | Craft.co
Mammoth Biosciences's Co-Founder, Chief Executive Officer & Board Member is Trevor Martin. Other executives include Keith Abe, Director, Translational In Vivo Pharmacology; Janice …See details»
Bayer trumpets $1bn CRISPR deal with Mammoth Bio
4 days ago Bayer has bolstered its cell and gene therapy platform by securing access to a CRISPR-based gene-editing platform developed by US biotech Mammoth Biosciences. The German group is paying $40 ...See details»
Mammoth Biosciences - LinkedIn
Mammoth Biosciences | 40,194 من المتابعين على LinkedIn. Improving lives by reading and writing the code of life. | Mammoth Biosciences is a biotechnology company focused on leveraging its …See details»
Mammoth Biosciences - Funding, Financials, Valuation & Investors
Mammoth Biosciences is funded by 27 investors. Bradley Horowitz and Plum Alley are the most recent investors. Mammoth Biosciences has a post-money valuation in the range of $500M to …See details»
A Brief History of Mammoth Biosciences – …
Dec 19, 2024 Founding and Origins of Mammoth Biosciences. Mammoth Biosciences was founded in [year] by [founders' names] with the vision of harnessing the power of CRISPR …See details»
Mammoth Biosciences (SMF2ALZMSRA5) - highergov.com
Mammoth Biosciences (UEI SMF2ALZMSRA5, CAGE 83CY6) based in Brisbane CA federal contracts, grants, registrations, vehicles, partnerships, and analysis ... //www.mammoth.bio. …See details»
'Riding a tiger' from lab to C-suite with Mammoth's Janice Chen
May 16, 2023 The COVID pandemic was a make or break moment for many a biotech. At Mammoth Biosciences, it may have been a little of both. For Janice Chen, Ph.D., the CRISPR …See details»
Regeneron and Mammoth Biosciences Collaborate to Pursue Next …
Apr 25, 2024 Mammoth’s proprietary ultracompact CRISPR-based gene editing platform and Regeneron’s proprietary delivery technologies set to advance in vivo programs in multiple …See details»
Mammoth Bio scores $195M top-up to supercharge CRISPR …
Sep 9, 2021 Mammoth launched in April 2018 with CRISPR technology licensed from the lab of Jennifer Doudna, Ph.D. and a mission to create a point-of-care diagnostic tool that can test for …See details»
Protein Discovery - Mammoth Biosciences
Protein Discovery and Engineering Discovering and engineering novel CRISPR systems and technologies We are addressing the current challenges of CRISPR-Cas systems such as in …See details»
Regeneron signs Mammoth gene editing deal worth $100M upfront
Apr 25, 2024 Mammoth Biosciences, that is. The two companies will collaborate on in vivo CRISPR-based gene editing therapies in a deal worth $100 million upfront plus $370 million in …See details»
Colossal Secures $200M in Series C Funding From TWG Global on …
Jan 15, 2025 In the last three years, Colossal’s first major project to be announced, the woolly mammoth project, generated new genomic resources, made breakthroughs in cell biology and …See details»
Woolly mice are a first step to resurrecting mammoths, but there's …
Mar 10, 2025 As a proof of concept, this research is fascinating, although it remains to be seen whether Colossal's goal of creating an elephant-mammoth hybrid by 2028 is achievable. It …See details»
Biotech Company Creates 'Woolly Mouse' as a Step in Its Quest to ...
Mar 4, 2025 The hairy mice are a “massive validating point” in the company’s quest to resurrect extinct species like the woolly mammoth, the thylacine and the dodo, says Ben Lamm, co …See details»
Company Seeking to Resurrect the Woolly Mammoth Creates a …
Mar 4, 2025 The biotech company Colossal Biosciences has long aspired to bring back the extinct woolly mammoth, which roamed the Northern Hemisphere thousands of years ago, …See details»